Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Infants and Toddlers in China

NCT07710872 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

4568

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningococcal Infection
Healthy Volunteers

Interventions

BIOLOGICAL: MenQuadfi® (Meningococcal Polysaccharide [Serogroups A, C, W, and Y] Tetanus Toxoid Conjugate Vaccine) (Sanofi Pasteur Inc., Swiftwater, PA, USA)
BIOLOGICAL: Menhycia® (ACYW135 Meningococcal Conjugate Vaccine [CRM197]) (CanSino Biologics Inc., China)

Sponsor

Sanofi